CLOFARABINE (Fresenius-Kabi)
Welcome to the PulseAid listing for the CLOFARABINE drug offered from Fresenius-Kabi. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius-Kabi |
| NON-PROPRIETARY NAME: | clofarabine |
| SUBSTANCE NAME: | CLOFARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-10 |
| END MARKETING DATE: | 0000-00-00 |
CLOFARABINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | CLOFARABINE from Fresenius-Kabi |
| LABELER NAME: | Fresenius-Kabi |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2017-05-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-572_171fac5c-1ab6-47d5-87d5-d23171f33cbd |
| PRODUCT NDC: | 63323-572 |
| APPLICATION NUMBER: | ANDA204029 |
Other CLOFARABINE Pharmaceutical Manufacturers / Labelers:
